- Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
- Antibiotics for preterm rupture of membranes
- Antibiotics for preventing recurrent urinary tract infection in non‐pregnant women
- Antibiotics for prolonged wet cough in children
- Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients
- Antibiotics for ureaplasma in the vagina in pregnancy
- Antibiotics for whooping cough (pertussis)
- Anticholinergic drugs versus non‐drug active therapies for non‐neurogenic overactive bladder syndrome in adults
- Anticholinergic drugs versus other medications for overactive bladder syndrome in adults
- Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
- Anticoagulants versus antiplatelet agents for acute ischaemic stroke
- Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack
- Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
- Anticoagulation versus placebo for heart failure in sinus rhythm
- Anticonvulsant drugs for acute and chronic pain
- Anticonvulsant drugs for migraine prophylaxis
- Anticonvulsant therapy for status epilepticus
- Anticonvulsants for alcohol withdrawal
- Anticonvulsants for cocaine dependence
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.